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Abstract.  Rubella virus (RV) has been reported to 
bud from intracellular membranes in certain cell 
types. In this study the intracellular  site of targeting of 
RV envelope E2 and E1 glycoproteins has been inves- 
tigated in three different cell types (CHO, BHK-21 and 
Vero cells) transfected with a cDNA encoding the two 
glycoproteins. By indirect immunofluorescence, E2 
and E1  were localized to the Golgi region of all three 
cell types, and their distribution was disrupted by 
treatment with BFA or nocodazole. Immunogold label- 
ing demonstrated that E2 and E1  were localized to 
Golgi cisternae and indicated that the glycoproteins 
were distributed across the Golgi stack.  Analysis of 
immunoprecipitates obtained from stably transfected 
CHO cells revealed that E2 and E1 become endo H 
resistant and undergo sialylation without being trans- 
ported to the cell surface. Transport of RV glycopro- 
teins to the Golgi complex was relatively slow (tta  = 
60-90 min).  Coprecipitation experiments indicated 
that E2 and E1  form a heterodimer in the RER. E1 
was found to fold much more slowly than E2,  suggest- 
ing that the delay in transport of the heterodimer to 
the Golgi may be due to the slow maturation of E1  in 
the ER. These results indicate that RV glycoproteins 
behave as integral membrane proteins of the Golgi 
complex and thus provide a useful model to study tar- 
geting and turnover of type I membrane proteins in 
this organdie. 
T 
hE study of enveloped viruses has been highly instru- 
mental  in  understanding  the  pathways  and  mecha- 
nisms  of intracellular  transport  in  eukaryotic cells. 
While  most  viruses  mature  at  the  plasma  membrane,  a 
limited number of viruses acquire their envelopes by bud- 
ding  into intracellular  compartments.  Viral assembly may 
take place on the inner nuclear membrane (herpesvirus),  ER 
membranes (coronavirus,  flavivirus,  and rotavirus),  inter- 
mediate  compartment  (coronavirus),  and  Golgi  complex 
(coronavirus,  bunyavirus,  and pox virus) (43).  The site of 
budding of a particular virus is likely determined by the tar- 
geting of one or more viral glycoproteins to the budding site. 
For this reason, viral glycoproteins have been useful tools for 
the study of protein targeting. 
Rubella virus  (RV)  t is a  Togavirus  which has been re- 
ported to bud from intracellular  membranes in  some cell 
types (4, 51). RV contains two envelope glycoproteins,  E2 
and El, both of which are type I membrane proteins,  and a 
capsid protein which associates with the positive-strand  ge- 
nomic  RNA in  the virion interior  (40).  The  subgenomic 
RNA which encodes these proteins (41) has been cloned and 
sequenced (10, 13, 14). Expression of the cDNAs encoding 
1.  Abbreviations  used in  this paper:  BFA,  brefeldin A; DFBS,  dialyzed 
FBS; NEM,  N-ethylmaleimide;  RV, rubella virus. 
E2 and E1 together or E1 alone in transfected  COS cells re- 
suited in their accumulation  in a juxtanuclear location sug- 
gestive of the Golgi (18). We have recently demonstrated that 
E1 expressed in the absence of E2 accumulates in a post-ER, 
pre-Golgi compartment composed of a network of tubular 
smooth membranes (20). In this paper,  we have studied the 
fate of E2 and E1 and have found that when expressed to- 
gether they are targeted to the Golgi cisternae in several cell 
types. Results obtained with agents that perturb the organiza- 
tion of the Golgi,  e.g., nocodazole and brefeldin A (BFA), 
indicate  that E2 and E1 behave as integral  membrane pro- 
teins  of the Golgi.  The results  suggest that  E2 and E1 are 
transported as a complex and retained in the Golgi appara- 
tus. Thus, one or both of these membrane proteins must con- 
tain a Golgi retention  signal. 
Materials and Methods 
Materials 
Reagents and supplies were obtained from the following sources:  BFA was 
from Epieentre Technologies (Madison, WI). Protein A- and G-Sepharose 
were purchased from Pharmacia (Alameda,  CA).  Geneficin (G418)  was 
from Gibco Laboratories (Grand Island, NY).  Fibronectin, SDS, nocoda- 
zole,  BSA,  and dialyzed  fetal FBS (DFBS) were purchased from Sigma 
Chemical Co.  (St.  Louis,  MO).  [35S]cysteine (1,000 Ci/mM)  was from 
ICN Biomedicals  Inc.  (Irvine,  CA).  Amplify,  14C-labeled protein stan- 
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Amersham Corp.  (Arlington Heights,  IL). Endoglycosidases  D (endo D) 
and H (endo H), and neuraminidase (Arthrobacter ureafaciens) were pur- 
chased  from  Boehringer  Mannheim  Biochemical  (Indianapolis,  IN). 
TRITC-conjngated  goat anti-mouse IgG and FITC-conjngated  donkey anti- 
rabbit IgG were purchased from Jackson Immuno Research Laboratories 
(West Grove,  PA). FITC-conjugated  goat anti-human IgG was purchased 
from Zymed Labs, Inc. (San Francisco, CA). Sulfo-NHS-biotin  and strep- 
tavidin agarose were obtained from Pierce Chemical Co.  (Rockford,  IL). 
The expression vector Moloney leukemia virus (MLV)-neo was a gift from 
Dr.  Alien Wells (University  of Alabama, Birmingham, AL). 
Antibodies 
Human anti-rubella virus serum was  obtained from Dr.  Aubrey  Tingle 
(University of British Columbia, Vancouver,  B.C.).  Mouse monoclonais 
against E2 and El (ascites) were kindly provided by Dr. John Safford (Ab- 
bott Laboratories, North Chicago,  IL). Polyclonal  rabbit anti-RV  serum 
was a gift from Dr. Christian Oker-Blom (Abo Akademi, Turku, Finland). 
Rabbit anti-lgp 120 serum was provided by Dr. W'dliam Dunn (University 
of Florida, Gainesville,  FL). Rabbit antibodies to the rat cation-indepen- 
dent maunose-6-phosphate receptor were  characterized previously  (9). 
Rabbit polyspecific  antiserum to ER membrane proteins was from Dr. D. 
Louvard (Pasteur Institute, France) (31). mAb to a conserved epitope on 
the endodomain of human transferrin receptor was a gift from Dr. Ian Trow- 
bridge (Saik Institute, La Jolla, CA). Rabbit antiserum to ct-mannosidase 
II (man II) was prepared with antigen provided by Dr.  Kelley Moremen 
(University of Georgia, Athens, GA) using antigen prepared as described 
(39).  Mouse mAb BWSG5 to the luminal domain of VSV G protein was a 
gift from Dr.  W'dliam Baich (Scripps  Research Institute,  La Jolla, CA). 
Mouse monoclonal antibody (X22) to clathrin heavy chain was obtained 
from Dr.  Francis Brodsky (University of California, San Francisco,  CA) 
and rabbit anti-/~-COP  (anti-EAGE)  serum was a gift from Dr.  Thomas 
Kries (European Molecular Biology Laboratory, Heidelberg, Germany) (12). 
Cell Culture and Transfections 
CHOE2E1  are stably transfected CHO cells that express both E2 and E1 
glycoproteins  (20).  CHOE2  cells  were  established  by  cotransfecting 
CHODG44 cells with pCMVSE2 (18) and pFR400 as described (20). The 
RV genes are under the transcriptional control of the human cytomegaiovi- 
rus immediate early promoter in the expression vector pCMV5  (1,  18). 
Cells were grown in MEM a supplemented with 10 % DFBS, 100 U/rnl pen- 
icillin, 100 ~g/ml streptomycin and 2 mM glntamine at 37°C in a 5% CO2 
incubator. Vero cells and BHK-21 cells were grown in MEM supplemented 
with 10% FBS, antibiotics and glntamine. Stable BHK-21 lines expressing 
RV E2 and El were obtained by transfecting (using Lipofectin) the cells with 
a eDNA encoding RV E2 and E1 (18) subcloned downstream from the MLV 
long terminal repeat in the vector MLV-neo. Transfectants were selected by 
culturing in 700 ttg/ml O418 for 12-14 d after which colonies were picked 
and  expanded.  Clones were screened  by  indirect  immunofluorescence  using 
human anti-RV  serum.  FOr  transient  transfection  of  Vero  and  BHK-21 cells, 
experiments  were  performed 2 d after  transfection  (Lipofectin)  with  pCM- 
V5E2EI  (18). 
Immunofluorescence Microscopy 
Cells were plated onto fibronectin-coated (10/~g/ml) chamber slides or 12 
mm glass coverslips at a density of 2 x  104 coils/era 2. After 2 d, cells were 
washed four times in PBS containing 0.5 mM Mg  2+ and then either fixed 
and permeabilized with 100% methanol at -20°C (6 rain), or fixed with 
2% paraformaldehyde  in PBS (15-20 rain) and permeabilized with 0.1% 
Triton X-100. They were then washed three times with PBS followed by in- 
cubation with PBS/I% BSA to block nonspecific binding. Primary and sec- 
ondary antibodies were diluted in PBS/1% BSA, and incubations were for 
I h at room temperature. Cells were mounted in 90% glycerol/PBS contain- 
ing  1 m~/mi paraphenylinediamine, examined  and photographed with a 
Zeiss Axiophot. Where indicated, cells were incubated with media contain- 
ing 2/tg/ml BFA, 25/tg/ml nocodazole,  or 250/~M cyclohexamide for the 
indicated time periods before fixation. 
Metabolic Labeling and Radioimmunoprecipitation 
Subconfluent monolayers in 35-ram dishes were washed (two times) in PBS, 
incubated in cysteine-free MEM/10%  DFBS for 30 rain at 37°C, and pulse 
labeled with 200-1,000  t~Ci/rnl  [35S]cysteine  for the indicated  time 
periods.  Post  pulse,  the  cells  were  incubated  with  complete  media  contain- 
ing  50x excess  unlabeled  cysteine.  Cells  were washed (three  times)  with 
cold  PBS and  lyscd  by incubation  in 150 mM  NaCl, 50  mM  Tris-HCl  (pH 
8.0),  I% NP40, 0.5% sodium  deoxychoiate,  0.1% SDS containing  protease 
inhibitors  (l  ~g/ml chymostatin,  leupeptin,  antipain  and  pepstatin  A)  on  ice 
for 15 rain.  The lysates  were centrifilged  at top speed for 3 rain  in a 
microfuge,  and  the  supcrnatants  were  incubated  with  primary antibodies  at 
4°C for  at  least  3 h before  addition  of  protein  A or G-agarose  beads.  Im- 
munoprecipitates  were  washed  (three  times)  with  RIPA  buffer  (50  mM Tris- 
HCI, pH 7.5;  150  mM  NaCl; I% NP40; 0.5% sodium  dcoxycholate;  0.1% 
SDS) and  once with  water,  and subjected  to SDS-PAGE and fluorography 
as described  (20). 
When coprecipitation  orE2 and  El was  being  examined,  cells  wcrc  solu- 
bilized  in  50  mM  Tris-HCl  (pH  7.4),  150 mM  NaCl, 2 mM  EDTA and I% 
NP40, and  immunoprecipitates  were washed  twice  in  NET buffer  (50  mM 
Tris-HCl  pH 7.4,  150  mM NaCI,  0.1% NP40,  0.25% gelatin)  and  once with 
I0 mM  Tris-HCl (pH 7.4)  and 0.1% NP40. 
To examine folding  of  El and E2, CHOE2EI cells  were pulse  labeled 
for  2.5 rain  with [35S]cysteine  (I,000  pCi/ml) and chased with  100x ex- 
cess  cysteine.  Before  lysis,  cells  were  washed  with  PBS containing  20 mM 
N-ethylmaleimidc  (NEM) to  alkylate  free  sulfnydryl  groups  (8,  35).  Immu- 
noprecipitates  were  prepared  using  rabbit  anti-RV  serum  or  human anti-RV 
as  above  and  subjected  to  SDS-PAGE under  reducing  or  nonreducing  condi- 
tions.  In nonreduced samples,  ~mcrcaptocthanol was omitted from the 
SDS-gcl sample buffer. 
Cell Surface Immunoprecipitation 
Cells were pulse labeled with [35S]cysteine and chased with excess unla- 
beled cysteine  for the indicated time periods. Afterwards  the cells were 
washed with ice-cold PBS, and cell surface proteins were biotinylated by 
incubation with Sulfo-NHS-biotin  (1 mg/ml in PBS) for 30 min at 4°C with 
occasional  rocking  (29).  Biotinylation  reactions  were  terminated  by 
quenching with PBS containing 50 mM lysine, and RV glycoproteins  were 
immunoprecipitated from cell lysates as described above. Immune com- 
plexes were dissociated by successive boiling in 2  x  100/LI aiiquots of 200 
mM Tris-HCl (pH 8.8); I% SDS; 5 mM EGTA.  Biotinyiated RV proteins 
were recovered by incubating one half of the eluate with 50 ~1 of a 50% 
slurry of streptavidin  agarose at 4°C for 30 min. The beads were washed 
as above and the biotinylated RV antigens were eluted in SDS gel sample 
buffer and subjected  to SDS-PAGE and fluorography.  The fraction of RV 
glycoproteins  present in intracellular and cell surface pools was estimated 
by liquid scintillation counting of aliquots  of the immunoprecipitates. 
Endo H, Endo D and Neuraminidase Digestions 
For endo H digestions,  immunoprecipitates were released from the protein 
A-Scpharosc beads by heating in 0.5%  SDS,  100 mM sodium citrate (pH 
5.5) at 100°C for 5 rain. The eluates were diluted with an equal volume of 
100 mM sodium citrate buffer (pH 5.5) and incubated with or without 2.5 
mU endo H for at least 8 h at 37°C  (17). For endo D digestions,  eluates 
were adjusted to 50 mM sodium citrate (pH 6.5),  10 mM EDTA, 2% Triton 
X-100, 0.25% SDS and incubated with 2.5 mU endo D for at least 8 h at 
37°C  as  described (20).  Neuraminidase digestions  were  performed by 
resnspending immune complexes (still attached to protein A-Sepharose) in 
50 mM sodium acetate (pH 5.4) containing protease inhibitors (see above) 
followed by incubation at 37°C for 4 h with or without neuraminidase (1 
U/ml) from A. ureafaciens.  Immune complexes  were then dissociated  in 
sample buffer and separated  by SDS-PAGE. 
SDS-PAGE and Autoradiography 
Proteins were separated on 10% polyacrylamide  gels (26). Gels were fixed 
in isopropanol:water:acetic  acid (25:65:10) and soaked in Amplify (Amer- 
sham Corp.) before drying and exposure  to Kodak XAR film at -80°C. 
Electron Microscopy and Immunogold Labeling 
For routine morphology studies, cells were fixed (1 h) with 2 % glutaraide- 
hyde,  3% paraformaldehyde in 100 mM cacodylate-HCl  buffer, pH 7.2, 
scraped from the culture dish, and pelleted in a microfuge.  The cell pellets 
were then postfixed (1 h) in 2% OsO4 in the same buffer, stained in block 
(2 h) with 2 % uranyl acetate (pH 6.0), dehydrated  in graded ethanols and 
embedded in Epon. 
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0.05 % glutaraldehyde in 100 mM cacodylate-HCl-buffer, pH 7.4 (1 h), after 
which they were scraped from the culture dish, pelleted in a microfuge and 
cryopmtected by infiltration with 2.3 M sucrose in 0.1 M phosphate buffer, 
pH 7.4, containing 20% polyvinylvyrrolidone, and then mounted on alumi- 
num nails and frozen in liquid N2 (49).  Ultrathin cryosections prepared 
from the pellets were collected on carbordformvar coated nickel grids and 
incubated for I h in mouse monoclonal anti-El or E2 ascites (diluted 1/300 
in 10% FCS/PBS),  followed by rabbit anti-mouse IgG (1 h) and goat anti- 
rabbit IgG-gold (5 nm) conjugate (diluted 1/50) for 1 h. Grids were stained 
in 2 % neutral uranyl acetate (20 rain) and absorption stained with 0.2 % ura- 
nyl acetate  (10 rain) in 0.2% methylcellulose, and 2% carbowax. 
Infection of CHOE2EI Cells with VSV ts045 
CHOE2EI  cells grown in 35 mm dishes were infected 2-3 d after seeding 
with VSV ts045 (provided by Dr. William Balch, Scripps Research Insti- 
tute).  Cells  were washed twice with serum-free MEM ot containing one 
sixth the normal amount of sodium bicarbonate plus I0 mM Hepes (pH 7.2) 
before addition of virus. Virus was allowed to bind to cells for 60 rain at 
32°C. The virus-containing media was removed and replaced with the same 
media containing  10% FBS, and the cells were incubated at 32°C for 4 h. 
They were then incubated in cysteine-free media for 30 rain, labeled for 10 
min at 37°C with [35S]cysteine, chased for 0 or 60 rain at 32°C followed 
by treatment with sulfo-NHS-biotin as above. 
Results 
Rubella Virus Glycoproteins Are Localized to the 
Col# Complex 
RV has been reported to bud from either intracellular mem- 
branes (BHK-21 cells) or the plasma membrane (Vero cells) 
(4).  The site of virus assembly is likely determined by the 
targeting of the E2-E1  spike complex. To determine if dif- 
ferential targeting occurred, pCMVSE2E1 (18) was used to 
transfect these two cell lines. In stably transfected BHK-21 
cells, both E2 and E1 colocalized with the resident Golgi gly- 
coprotein cx-mannosidase II (man II) by indirect immuno- 
fluorescence (Fig.  I, A-D). Similar results were obtained in 
transiently transfected cells (not shown). Next we examined 
transiently  transfected Vero cells and  found,  surprisingly, 
that E2 and E1 glycoproteins also appear to be retained in 
the Golgi complex (Fig.  1 E). It should be noted, however, 
that we used a cDNA from a different strain of RV than that 
used in the previous study (4). Our results suggest that RV 
E2 and E1 are targeted to the Golgi of both BI-IK-21 and Vero 
cells. 
Figure 1. RV E2 and E1 glyco- 
proteins  are  targeted  to  the 
Golgi complex of both BHK- 
21 and Vero cells. Cells trans- 
fected with pCMVSE2E1 were 
grown on coverslips, fixed and 
permeabilized with methanol 
at -20°C, and double-labeled 
with mouse monoclonal to ei- 
ther E1 or E2 (left) and rabbit 
anti-man II  (right)  to visualize 
the  Golgi complex  followed  by 
TRITC-goat  anti-mouse  IgG 
and FITC-donkey  anti-rabbit 
IgG.  (A-D)  Stably  transfected 
BHK-21  were stained  for ei- 
ther  E1 (A)  or  E2 (C)  and  man 
II  (B and D). Staining  for  El 
and E2 coincides with that for 
the Golgi marker man II. (E) 
Xlero  cells  were  transiently 
•  ansfected and stained for E2 
and  El.  The viral glycopro- 
teins  are concentrated  in the 
Golgi region where they over- 
lap with man II. Bar, 5 #m. 
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RV E2 and E1 glycoproteins  is 
disrupted by BFA and nocoda- 
zole.  (A  and  B)  CHOE2E1 
cells grown on coverslips  were 
incubated with BFA (2 #g/ml) 
for 60 rain and processed for 
double staining with either E1 
(left) or man II (right)  by in- 
direct  immunofluorescence. 
Staining for  both RV glycopro- 
reins and man H is dispersed 
into a diffuse vesicular  pattern. 
(C-F)  Cells  incubated  with 
BFA for 60 rain, after which 
BFA was removed and replaced 
with medium containing 500 
#M cycloheximide for 20 (C, 
D) or 40 (E, F) min. Staining 
for man II has relocaiized to 
the Golgi region as has most 
of the El. Some vesicles con- 
taining only E1  are dispersed 
throughout  the  cytoplasm. 
(G-H) CHOE2E1  cells were 
incubated  with  nocodazole 
(25/~g/ml) for 60 rain at 37°C 
before processing for double 
immunofluorescence. Staining 
for both E1 and man II is dis- 
persed  after  this  treatment. 
Identical results were observed 
when cells were stained for E2 
(not shown).  Bar, 5 #m. 
Figure 2.  RV E2 and E1  are retained in the Golgi complex of CHO cells. Stably transfected CHO cells (CHOE2E1) expressing E2 and 
E1 were grown on coverslips and processed for indirect immunofluorescence as described for Fig. 1. (A and B) Cells doubly stained for 
E1 and man ft. (C and D) Cells doubly stained for E2 and man II. (E and F) Cells were treated with 500/~M cycloheximide for 3 h before 
fixation (CHX 3 h) and doubly stained for E1  and man H.  (G and H) Cells similarly treated and doubly stained for E2 and man II. In 
all cases staining for RV glycoproteins coincides with that of man II. Bar, 5 ~,m. 
Hobman et al. Golgi-specific Viral Glycoproteins  273 Figure 4.  RV glycoproteins are distributed across the Golgi stack.  Ultrathin cryosections were incubated with either mouse anti-E1  (A) 
or anti-E2 (B),  followed by rabbit anti-mouse IgG (used as a bridging antibody)  and goat anti-rabbit IgG coupled to 5  nm gold.  Both 
E1 and E2 are detected across the Golgi stack (Gc) and within associated vesicles, but they are not detected in rough ER (er) membranes. 
Gold particles are more concentrated on one side of the stack (arrowheads) than the other,  n  =  nucleus. Bar, 0.5 #m. 
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ing transport of E2 and E1 to the Golgi, biochemical analysis 
of the RV glycoproteins by radioimmunoprecipitation from 
transfected BHK-21 cells indicated relatively low levels of 
expression in this cell line. To facilitate ultrastructural and 
biochemical analysis of these glycoproteins, we used stably 
transfected CHO cells expressing RV E2 and E1 (CHOE2E1) 
because moderate levels of expression are easily achieved in 
CHO cells (20). CHOE2E1 cells contained E2 and E1 pri- 
marily in the Golgi region as indicated by colocalization with 
man II (Fig. 2, A-D). No increase in cell surface expression 
of E2 and E1 was seen after treating CHOE2E1 with cyclo- 
heximide for 3 h (Fig. 2, E-H), suggesting that the bulk of 
these proteins is stably retained in the Golgi. 
Distribution of  E2 and E1 Glycoproteins Is Disrupted 
by Agents which Perturb the Golgi 
BFA and nocodazole cause rapid, reversible disassembly of 
the Golgi in many cell types (23, 45).  To determine their 
effects on the distribution of RV glycoproteins, CHOE2E1 
cells were treated with nocodazole (25  /~g/ml) or BFA (2 
#g/rra). 
BFA treatment led to dispersal of both man II and E1 to 
a diffuse localization (Fig. 3, A and B). Similar results were 
obtained when cells had been treated with cycloheximide for 
3 h before BFA treatment (not shown). Nocodazole treatment 
resulted in dispersal of the Golgi into vesicular structures, 
most of which contained both RV glycoproteins and man II 
(Fig. 3, G and H). Identical results were obtained using an 
anti-E2 monoclonal antibody. These results indicate that E2 
and E1 behave as integral membrane proteins of the Golgi 
complex. 
To determine the fate of RV glycoproteins during reassem- 
bly of the Golgi, BFA-containing media were removed and 
replaced with media containing cycloheximide. 20 rain after 
BFA  washout,  E1  was  found mainly in  the  Golgi region 
where it largely colocalized with man II (Fig. 3, C and D). 
Interestingly, between 40 (Fig. 3, E and F) and 60 re.in after 
BFA removal, E1 persisted in vesicular structures found in 
peripheral regions that did not contain man II (Fig. 3, E and 
F). These structures were no longer seen at 2 h after BFA 
washout (not shown). Similar results were obtained with E2. 
Increased levels of E2 and E1 were also seen at the cell sur- 
face 60 min after BFA washout (not shown). The nature of 
these E2El-containing structures remains unclear; they did 
not colocalize  with markers for lysosomes (lgp 120), or early 
(transferfin receptor) or late (mannose-6-phosphate recep- 
tor) endosomes, and they did not stain for/3-COP or clathrin 
suggesting that they are not pre- or post-Golgi transport vesi- 
cles (not shown). Furthermore, they are not of RER origin 
because they were not stained by a polyspecific antiserum 
that  recognizes four ER membrane proteins  (not  shown) 
(31).  The results of the BFA washout experiments suggest 
that although most of the RV glycoproteins may reside in the 
same intraGolgi location as man II, a fraction of the E2 and 
E1 pool may reside in a different region of the Golgi. 
Rubella Virus E2 and E1 Are Distributed across the 
Golgi Stack 
To determine precisely where in the Golgi complex E2 and 
E1 are localized, E2 and E1 were localized by immunogold 
labeling  of ultrathin  cryosections.  The  RV  glycoproteins 
were detected in all cisternae throughout the Golgi stack as 
well as within vesicles of uniform size in the vicinity of this 
organelle (Fig. 4, A and B). Very little labeling of the rough 
ER was detected. In favorable sections, a gradient of gold 
particles was seen across the stack with labeling on one side 
greater than that on the other. Similar results were obtained 
Figure 5.  E2 and E1 become 
resistant  to  endo  H.  CHO- 
E2E1 cells were pulse labeled 
for 30 min with [35S]cysteine 
followed  by chase for the indi- 
cated  time  periods  (in  min- 
utes). E2 and E1 were immu- 
noprecipitated  from cell lysates 
with  human  anti-RV serum 
(precipitates both E2 and El) 
and digested with (+) or with- 
out (-) endo H. Samples were 
subjected to SDS-PAGE and 
fluorography. 14C-labeled  pro- 
tein standards  (kD) were in- 
cluded for reference. Immedi- 
ately postpulse E2 and E1 have 
apparent molecular weights of 
39 and 57 kD, respectively (ar- 
rows), and are endo H sensi- 
tive. By 30 min chase endo H 
resistant forms, 45 and 60 kD, 
are detected, and by 180 min 
>90%  of the E2 and E1 be- 
come endo H  resistant.  The 
asterisk marks the position of 
the Golgi-processed (endo H 
resistant) form of E2. 
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not possible to determine which side was more heavily la- 
beled due to the lack of markers  indicating the cis/trans 
polarity. These results demonstrate that E2 and E1 accumu- 
late in bona fide Golgi elements. 
Rubella Virus Glycoproteins Become Endo H Resistant 
and Acquire SiaUc Acid 
E2 containsthree N-linked (10, 44) as well as O-linked gly- 
cans (32), whereas E1 contains only three N-linked glycans 
(19, 32). To obtain information on the extent of processing 
of El and E2 by Golgi enzymes, CHOE2E1 cells were pulse 
labeled  with  [35S]cysteine  and  chased  for  various  time 
periods before lysis and immunoprecipitation with human 
anti-RV sera that recognize both E2 and El. Immunoprecipi- 
tates were divided into two and incubated with or without 
endo H before separation by SDS-PAGE and autoradiogra- 
phy (Fig. 5). The apparent molecular weights of E2 and E1 
immediately after the labeling period are  39  and  57  kD, 
respectively  (18).  Their  sensitivity  to  endo  H  digestion 
demonstrated  that  they  correspond to  high-mannose,  ER 
forms of the glycoproteins. Chase with media containing ex- 
cess unlabeled cysteine resulted in acquisition of endo H re- 
sistance with a t~ of I-1.5 h indicating transport of E2 and 
E1 to the middle Golgi. Processing of E2 and E1 was detect- 
able at 0.5 h chase and by 3 h chase >90% of E1 and E2 were 
resistant to endo H. The Golgi processed, endo H-resistant 
forms of E2 and E1 were 42--47 and 57-66 kD, respectively 
(Fig. 5). The large shift in size of  processed E2 seen by SDS- 
PAGE is  at least in part due to the presence of O-linked 
oligosaecharides  (32).  The  fact that  Golgi processing  of 
N-linked glycans on E2 and E1  proceeded at similar rates 
suggests that these proteins may be transported to the Golgi 
as a complex. Endo D sensitive forms of E2 and E1 were not 
detected at any time point (not shown) suggesting that trans- 
port is not delayed in the cis Golgi. 
Immunoprecipitates were also digested with a neuramini- 
dase (A.  ureafaciens) which has a  broad-range specificity 
and cleaves sialic acid from both N- and O-linked glycans 
(30). The endo H resistant forms of both E2 and E1 became 
partially  sensitive  to  neuraminidase  in  a  time-dependent 
manner (Fig. 6) indicating that at least a portion of these gly- 
coproteins were modified by sialyltransferases. Neuramini- 
dase digestion affected only the endo H-resistant forms (>60 
min chase) of RV glycoproteins indicating that some but not 
all of their electrophoretic heterogeneity was due to sialic 
acid. The neuraminidase-sensitivity of E2 was more difficult 
to  discern  (Fig.  6)  due  to  the  heterogeneous  nature  of 
neuraminidase-digested E2.  It has been recently reported 
that sialylation of O-linked oligosaccharides may occur in 
the medial Golgi (30), whereas sialylation of N-linked gly- 
cans occurs in the TGN. The finding that El, which contains 
only N-linked glycans, was partially sensitive to neuramini- 
dase suggests that a significant proportion of these glycopro- 
teins reach trans Golgi eisternae. 
Biosynthetic labeling experiments were also carried out on 
CHOE2 cells expressing only E2. In these cells, very little 
processing of N-linked glycans on E2 was observed after a 
3 h chase (not shown), and by indirect immunofluorescence 
the majority of the glycoprotein appeared to be retained in 
the RER. However, some antigen was detected in the Golgi 
Figure 6.  E2 and E1 undergo sialylation.  CHOE2E1 cells were 
pulse-labeled and processed for irnmunoprecipitation as in Fig. 5. 
E2 and E1 immunoprecipitates were digested with (+) or without 
(-) neurarninidase from A. ureafaciens. Neuraminidase-sensitive 
forms of E2 and E1 are first clearly evident at 120 min. Neurarnini- 
dase sensitivity of E2 is indicated by the decrease in intensity of 
the 47-kD species (asterisk) after treatment,  and neuraminidase 
sensitivity of El is indicated by a reduction in the size of El. 
based on colocalization with man II, and extremely low lev- 
els of E2 could be detected on the cell surface of nonpermea- 
bilized cells (not shown). We conclude that the majority of 
E2 expressed in the absence of E1 remains in the ER, but a 
minor fraction is transported to the Golgi and cell surface. 
The Majority of  the Rubella Virus Spike Complex Is 
Retained in the Golgi 
The results  obtained by indirect immunofluorescence and 
immunogold labeling of CHOE2E1 cells suggested that the 
bulk of  the E2 and E1 remains in the Golgi. To confirm by an 
alternative approach that the majority of these proteins do 
not reach the plasma membrane, we utilized a commercially 
available reagent (sulfo-NHS-biotin) that has been used to 
selectively biotinylate primary amines of cell surface pro- 
teins (27). The biotinylated proteins subsequently can be iso- 
lated  using  streptavidin-agarose  and  thus,  easily  distin- 
guished  from  the  intracellular  pool.  When  radiolabeled 
CHOE2E1 cells were treated with sulfo-NHS-biotin to bi- 
otinylate cell surface proteins, <10% of either glycoprotein 
was detected at the cell surface after 180-min chase even 
though they had clearly entered the Golgi as evidenced by 
their  increased  molecular  weight  (Fig.  7).  CHOE1  cells 
which contain large amounts of E1 arrested in a pre-Golgi 
compartment (20) were used as a negative control. E1 was 
not detected at the surface of CHOE1 cells using the biotiny- 
lation  protocol  (Fig.  7).  As  a  positive  control,  when 
CHOE2E1  cells were infected with VSV ts045,  G protein 
was transported to the cell surface at 32°C where it could 
be biotinylated and subsequently isolated using streptavidin- 
agarose (data not shown).  From these results we conclude 
that (a) the majority of E2 and E1 do not reach the plasma 
membrane in CHOE2E1 cells, and (b) although transport of 
E2 and E1 is arrested in the Golgi complex, their accumula- 
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RV spike complex is not trans- 
ported  to  the  cell  surface. 
CHOE2E1 (E2E1) and CHO- 
E1 (El) cells were radiolabeled 
for 30 min and chased for the 
indicated times (in minutes). 
Cell  surface  proteins  were 
biotinylated with sulfo-NHS- 
biotin. RV proteins were im- 
munoprecipitated  from  cell 
lysates using human anti-RV 
serum and divided into two ali- 
quots.  Biotinylated cell  sur- 
face proteins were recovered 
from one half using streptavi- 
din agarose, and the remaining 
half constituted the intracellu- 
lar sample. Samples were then 
subjected to SDS-PAGE and 
fluorography.  The  protein 
marked by the asterisk is be- 
lieved  to be a degradation  prod- 
uct of El. Very little (<10%) 
of the  E2 or E1  reaches the 
cell surface in cells expressing 
both  proteins.  As  a negative 
control, E1 is not detected at 
the cell surface  in cells express- 
ing E1 alone. (Note: because 
so little of the RV glycopro- 
teins was recovered in the cell 
surface  fractions,  the  entire 
cell  surface  samples were 
loaded onto gels whereas only 
one half of the  intracellular 
fractions were loaded). 
tion does not prevent the egress of other glycoproteins from 
this organelle. 
Folding of  E2 and El Occur at Different Rates 
The data presented here and in previously published work 
(5, 6,  18) are consistent with the assumption that E2 and E1 
form a heterodimer in the ER that is transported as such to 
the Golgi complex.  Furthermore,  the fact that the tla  for 
acquisition ofendo H resistance is 1-1.5 h indicates that trans- 
port to the medial/trans Golgi is slow. The simplest explana- 
tion for this delay in exiting the ER is that considerable time 
is required for folding and acquisition of correct tertiary and 
quaternary structures by RV glycoproteins in the ER.  The 
folding  of glycoproteins and  formation of intramolecular 
disulfide bonds in the ER can be monitored by SDS-PAGE 
of the proteins under nonreducing conditions. Proteins that 
have  not yet completed the  formation of their intrachain 
disulfide  bonds  typically  migrate  with  a  slower  elec- 
trophoretic mobility, presumably because they are in an ex- 
tended conformation (8,  35).  To compare the folding rates 
of E2 and El,  CHOE2E1 cells were pulse labeled for 2.5 
min,  chased for various times with excess unlabeled cys- 
teine,  and  treated  with  NEM  before  lysis  (8,  35).  Im- 
munoprecipitates were subjected to SDS-PAGE under non- 
reducing  (Fig.  8  A)  and  reducing  (Fig.  8  B)  conditions. 
Immediately after the pulse, one prominent El species and 
two faint bands were evident when samples were separated 
under nonreducing conditions. However, very little E2 was 
recognized by the polyclonal anti-RV serum at this time point 
(Fig. 8 A). After a 2 min chase, a faint homogeneous E2 band 
was detected, whereas E1 still migrated as at least two dis- 
tinct species in the absence of reducing agent. In contrast, 
under reducing conditions E1 did not display electrophoretic 
heterogeneity (Fig.  8 B).  With increasing chase time,  the 
mobility of nonreduced E2 did not change, whereas the mo- 
bility of El increased (Fig. 8 A). The two slower migrating 
forms of E1  present at  early time points  likely represent 
forms of the protein that have not attained their full comple- 
ment ofintrachain disulfide bonds. After 60-min chase, most 
of the E1 was present as the faster migrating compact form, 
Using a human anti-RV serum that recognizes only mature 
forms of E1 and E2, we also found that maximal expression 
of epitopes on E2 occurred between 5 and 15 min whereas 
E1 required up to 60 min (not shown). These results suggest 
that formation of intramolecular disulfide bonds and folding 
of E1 (which has 24 cysteine residues), occurs much more 
slowly than E2 which has only 13 cysteine residues (10). 
The quaternary structure of the RV  spike complex was 
examined  via  coprecipitation  experiments.  Radiolabeled 
Hobman et al. Golgi-specific  Viral Glycoproteins  277 Figure 8.  Disulfide  bond formation occurs more rapidly in E2 than in [/1. CHOE2E1  cells  grown in 35-ram dishes  were pulse labeled 
with [35S]cysteine  (1,000/~Ci/ml)  for 2.5 rain at 37°C.  Prewarmed chase medium (2.5 ml) containing 100X excess unlabeled  cysteine was 
added after the pulse, and the cells were incubated for the indicated time periods (in minutes).  Cells were washed in ice cold PBS containing 
20 mM NEM before lysis and radioimmunoprecipitation with rabbit anti-RV serum. Immunopreeipitates were separated under nonreducing 
(A) and reducing (B) conditions by SDS-PAGE. Disulfide formation in E2 appears to be completed by 5 min whereas folding of E1 requires 
up to 60 min. 
CHOE2E1 cells were solubilized under mild conditions (1% 
NP-40 in isotonic Tris-saline) to preserve protein-protein in- 
teractions between E2 and El. A mAb to E2 was used to pre- 
pare  immunoprecipitates  from CHOE2E1  cells  at various 
chase times after a short (5 rain) pulse. Immediately after the 
pulse,  a  faint E2 band was seen in addition to a protein of 
,'~95 kD which likely represents the uncleaved E2E1 precur- 
sor polyprotein (Fig. 9). E1 coprecipitated with E2 as early 
as 5  min postpulse,  and the amount of E1  increased up to 
30-60  min  (Fig.  9,  right).  In contrast,  the  amount of E2 
precipitated reached a maximum between 5 and 15 rain (Fig. 
9).  Half of the  cell  lysates  were  also immunoprecipitated 
with a polyclonal anti-RV serum to demonstrate that E1 was 
present in the samples at all the time points (Fig. 9, left). The 
Figure  9.  E2  and E1  form a 
heterodimeric complex in the 
ER.  CHOE2E1  cells  were 
pulse-labeled  for 5 min with 
[35S]cysteine (1,000  /~Ci/ml) 
followed  by  incubation  with 
chase  medium  for  the  indi- 
cated  time  periods  (in  min- 
utes).  Cells  were solubilized 
in buffer containing 1% NP-40 
and immunoprecipitated with 
mouse anti-E2 (right)  or hu- 
man anti-RV serum (left) fol- 
lowed by SDS-PAGE and fluo- 
rography. E1 is coprecipitated 
by mouse monoclonal anti-E2 
(c~E2) beginning at 5 rain post- 
pulse (right) indicating that E2 
and  El  form  a  heterodimer 
in  the  ER.  Results  obtained 
with polyclonal  anti-RV serum 
(polyclonal c~RV) indicate that 
the amount of El does not in- 
crease during the chase period 
(after  5  mill),  whereas  the 
amount of El that  coprecipi- 
tates  with  E2 increases  up  to  30-60  rain.  The  large  protein  marked  by  an  asterisk  likely  represents  the  95  kD E2-EI polyprotein  precursor 
before  cleavage  by signal  peptidase.  The intensity  of  the  E2 (39  kD) and El (57  kD) bands decreases  after  60 rain  due to  processing  by 
Golgi enzymes and conversion  to  the larger  endo H-resistant  species. 
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points, i.e., before acquisition of endo H resistance (see Fig. 
5), indicates that heterodimer formation precedes exit from 
the ER. Because transport of RV glycoproteins to the Golgi 
(based on acquisition of endo H resistance [Fig. 5]) appears 
to occur at a similar rate, our results suggest that the folding 
of E1 may be the rate limiting step in heterodimer formation 
and subsequent transport to the Golgi. 
Discussion 
In this paper we have undertaken a comprehensive study of 
the assembly and transport of the RV E2 and E1 glycopro- 
teins in transfected cells and have shown that when these two 
proteins are expressed together they are targeted to the Golgi 
and behave essentially as integral Golgi membrane proteins. 
This conclusion is based on the findings that: (a) E2 and E1 
colocalized with the Golgi marker man 1/by immunofluores- 
cence in a number of cell types; (b) their Golgi localization 
was sensitive to agents that disrupt the Golgi such as nocoda- 
zole and BFA; (c) they were localized to the stacked Golgi 
cisternae  by immunogold labeling;  and  (d)  they became 
largely  resistant  to  endo  H  and  were  at  least  partially 
sialylated  but were not detected (<10%) on the plasma mem- 
brane, indicating that for the most part they were retained 
in the Golgi, We found that the time required for E2 and E1 
to mature, leave the RER and become endo H resistant was 
relatively long (tu2 =  1-1.5 h). This presumably was due to 
the time required for folding of  these proteins and maturation 
of the heterodimeric complex. Biosynthetic labeling experi- 
ments  indicated that E1  glycoprotein folded much  more 
slowly than E2. Coincidentally, processing of RV glycopro- 
teins by Golgi enzymes (detected after 30-rain chase) was 
not observed until heterodimer formation (as  detected by 
coprecipitation of E1  with anti-E2 monoclonal) reached a 
maximum (30-60 min). These results suggest that the matu- 
ration of E1 is the limiting factor in transport of the RV spike 
complex to the Golgi. 
IntraGolgi Location orE2 and E1 
At the light microscopic level, the location of E2 and E1 was 
indistinguishable from the medial Golgi marker man II ex- 
cept that occasionally the RV glycoproteins were detected in 
peripheral vesicles which did not contain man H. The fact 
that the majority of  the E2 and E1 glycoprotein became resis- 
tant to endo H and partially sialylated suggests that these gly- 
coproteins were transported to the medial and trans regions 
of the Golgi complex where the enzymes responsible for 
trimming (man II) and addition of sialic acid (sialyltransfer- 
ases) to N-linked oligosaccharides are assumed to reside. 
Unlike glycoproteins which traverse the Golgi completely, 
only a fraction of E2 and E1 appear to be modified by the 
addition of sialic acid. The fact that after BFA washout, in- 
creased levels of E2 and E1 were observed on the cell surface 
of nonpermeabilized cells could be explained if a fraction of 
the E2 and E1  complex reaches the "I'GN which has been 
reported to fuse with the endosomal network after BFA treat- 
ment (28,  52).  Thus, the structures observed during BFA 
washout that did not contain man II may represent trans 
Golgi/endosomal elements which recycle to the cell surface. 
Moreover, in favorable sections, immunogold labeling re- 
vealed a  polarized distribution or gradient of E2  and E1 
across the Golgi cisternae in CHOE2E1 cells. Although it is 
difficult to determine the cis-trans polarity of the Golgi in 
CHO cells by morphology alone, the fact that the majority 
of the E2 and E1 glycoproteins become endo H resistant and 
at least some of the N-linked glycans on E1  are sialylated 
support the conclusion that these proteins have a predomi- 
nantly medial/trans Golgi localization. 
Structure and Assembly of the E2/E1 Heterodimer 
Generally, only properly assembled oligomeric complexes 
are able to be efficiently transported from the ER (21, 47) 
whereas unassembled subunits are frequently retained and 
ultimately degraded (7, 24). In the case ofRV glycoproteins, 
expression of  E1 in the absence of  E2 results in transport from 
the RER to a tubular pre-Golgi compartment which is physi- 
cally connected to the RER (20).  When E2 was expressed 
alone in CHO cells, the majority of the protein was retained 
in the ER and to a  lesser extent in the Golgi. Only trace 
amounts of E2 were detected on the cell surface by indirect 
immunofluorescence. These  observations  suggest that E2 
and E1 must be expressed together to exit the ER and to be 
efficiently transported to the Golgi. Indeed, coprecipitation 
experiments indicated that E2 and E1 assemble into a hetero- 
dimeric complex in the ER. Because E2 and E1  associate 
shortly after synthesis (within 5 min) it is possible that the 
glycoproteins attain their tertiary structures by using each 
other as a  scaffold. The rate limiting step in heterodimer 
maturation is likely the folding rate of E1  which is much 
slower than that of E2. The situation appears to be similar 
in the case of the Uukuniemi virus G1 and G2 spike glyco- 
proteins which also form a heterodimer in the ER and are 
targeted to the Golgi (42). 
We were not able to detect oligomer formation compara- 
ble to that seen with other viral proteins (15, 50) in sucrose 
gradient velocity experiments; however,  it is possible that 
any higher order structures (e.g., trimers) formed may dis- 
sociate during centrifugation (16). 
Other Golgi-specific  Glycoproteins 
Other viral glycoproteins that localize to the Golgi include 
the coronavirus E1 glycoproteins (avian infectious bronchitis 
virus [37] and mouse hepatitis virus [2, 30, 48]) which have 
three membrane-spanning domains, and bunyavirus gtyco- 
protein  G1/G2  spike  complexes  which  have  only  one 
membrane-spanning domain (11, 22, 46). Bunyavirus glyco- 
proteins, like RV glycoproteins, are type I membrane pro- 
teins, whereas the integral Golgi membrane proteins that 
have been cloned and sequenced are type II membrane pro- 
teins (34).  The only exception to date is TGN38 which is 
found in the TGN (33). When the avian and mouse coronavi- 
rus  E1  glycoproteins are  expressed  using  vaccinia  virus 
recombinants, they have different intraGolgi sites of resi- 
dence, i.e., they are localized to the cis Golgi (36) and TGN 
(30), respectively. In the case of the avian E1 glycoprotein, 
retention signals responsible for targeting to the Golgi have 
been localized to its first membrane spanning domain (37), 
whereas in the mouse hepatitis virus E1 glycoprotein, the cy- 
toplasmic tail appears to be important but not sufficient for 
Golgi retention (3). Therefore, it is possible that the mecha- 
nism of retention of the two coronavirus E1  glycoproteins 
may be different. Golgi retention signals for type II Golgi 
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anchor domains and flanking  sequences (34). 
RV is perhaps most similar to bunyaviruses  in that a het- 
erodimer is formed between two type I membrane proteins 
which are then retained in the Golgi as a complex. Interest- 
ingly, both RV and bunyavirus  glycoproteins are unusually 
rich in cysteine residues (10,  11,  13,  14,  22, 46).  The in- 
traGolgi location of the various bunyavirus glycoproteins ex- 
pressed from cDNAs has not yet been determined by immu- 
noelectron microscopy. We have detected trace amounts of 
E2 and E1  glycoproteins on the cell surface of transfected 
cells with significantly more being detected on the surface 
of transiently  transfected COS cells (18) than in stably trans- 
fected CHO cells even though the ratio of intracellular  to cell 
surface label was the same (i.e., >90% of labeled RV glyco- 
proteins retained intracellularly  after 3-h chase). Typically, 
low levels of bunyavirus glycoproteins are also found on the 
surface of infected cells or cells expressing G1 and G2 from 
cDNA  (25,  38). 
RV Glycoproteins as Models for Golgi 
Membrane Proteins 
CHOE2E1  cells should prove to be very useful for further 
study of the synthesis, targeting and turnover of Golgi mem- 
brane proteins.  Expression of high levels of RV glycopro- 
teins does not significantly impair the growth of these cells 
and did not cause any obvious cellular abnormalities (i.e., 
autophagic vacuoles, vesiculated Golgi) in CHO cells. Thus, 
for all intents and purposes, RV E2 and E1 behave as endoge- 
nous  Golgi  membrane proteins  in CHO  cells  and should 
prove to be ideal for analysis of Golgi targeting  signals. Ac- 
cording to prevailing concepts, for proteins to be retained in 
the Golgi they must contain a Golgi retention signal (34). It 
follows that E2 and/or E1 must contain such a retention sig- 
nal for Golgi targeting  to occur. We are now attempting  to 
localize the Golgi retention signal(s) on the RV glycoproteins 
by constructing chimeras of E2 and E1 with proteins that are 
normally transported  to the cell surface. 
Finally, the availability of a biochemicaily and morpholog- 
ically well defined cell line expressing high levels of E2 and 
E1 together with their relatively slow rate of transport from 
the ER to the Golgi make CHOE2E1 cells an excellent alter- 
native  to cells infected with VSV G as a model system for 
further biochemical studies of ER to intermediate compart- 
ment and Golgi transport. 
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